FindTrial
Sign In

Development of Kamadugha rasa into mouth dissolving tablets and Effervescent granules form and comparative clinical efficacy in amlapitta.

Development of Kamadugha Rasa into Mouth dissolving Tablets and Effervescent granules form and their comparative clinical efficacy in Urdhwaga Amlapitta - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/086017
Enrollment
30
Registered
2025-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

BVVS Ayurved Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group 20 to 60 yrs and above Diagnosed patients of Urdhwaga Amlapitta

Exclusion criteria

Exclusion criteria: Patients diagnosed case of peptic ulcer duodenal ulcer etc Patients suffering from systemic disease like HTN DM CVD CKD and Carcinoma Pregnant womens and lactating womens

Design outcomes

Primary

MeasureTime frame
Development of Kamadugha Rasa into Mouth dissolving tablets and Effervescent granules form and their comparative clinical efficacy in Urdhwaga AmalpittaTimepoint: 15 days—

Secondary

MeasureTime frame
Aim and Objective of the study 1) To develop and compare the clinical effect of Kamadugha Rasa Mouth dissolving tablets and Kamadugha effervescent granules in Urdhwaga AmlapittaTimepoint: 15 days—

Countries

India

Contacts

Public ContactDR Prakash R Deshpande

BVVS Ayurved Medical College and Hospital

drprakashdeshpande76@gmail.com9482060186

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026